TRAIL is involved in the tumoricidal activity of mouse natural killer cells stimulated by Newcastle disease virus in vitro

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy

Role of mesenchymal stem cells in delivering Newcastle disease virus to glioma cells and glioma stem cells and enhancing the oncolytic effect of the virus by secreting TRAIL.

Outcome of an advanced anaplastic astrocytoma patient treated with Newcastle disease viral (NDV) oncolytic therapy.

The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling

Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future

Prostate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy

Two avirulent, lentogenic strains of Newcastle disease virus are cytotoxic for some human pancreatic tumor lines in vitro